Cipla Buying Opportunity1) The US recession talks are rising day by day. The recession is to come, we just don't know when, but it will come.
2) Inflation is at an all-time high. The IT sector is tanking like anything.
3) The Pharma sector is known to be recession-proof and inflation-proof. People will never stop spending on medicine and healthcare, no matter how expensive it gets.
4) Cipla is consolidating at its previous swing high.
5) The pharma sector has already corrected 1/3 after the 2020 rally.
6) almost all the sectors have recovered except for IT and PHarma. I believe if pharma rallies, then CIPLA will be the one leading the rally.
CIPLA trade ideas
CIPLAW PAttern Formation , Huge volumes coming up
Trading at 11.5% below our estimate of its fair value
Earnings are forecast to grow 17.22% per year
Pays a reliable dividend of 0.48%
Upcoming dividen of 5rs per share
Earnings vs Savings Rate: CIPLA's forecast earnings growth (17.2% per year) is above the savings rate (6.8%).
Earnings vs Market: CIPLA's earnings (17.2% per year) are forecast to grow faster than the Indian market (16.8% per year).